MedTech Dive January 26, 2023
Peter Green

Leaders from across the medtech field weigh in on the prospects and challenges for product regulation in 2023.

For medical device makers – and the patients who rely on them – 2023 is poised to be a year of challenge and change for regulation.

A post-COVID-19 surge in applications for review and the burgeoning role of artificial intelligence and machine learning — combined with swift advances in monitoring technology and wearable sensors — have pushed digital health to the fore.

That’s forcing the Food and Drug Administration to conceive of new ways to address the safety of devices that are continuously updating or even learning on the job.

In Europe, the European Commission has delayed its implementation of Medical...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Medical Devices, Regulations, Technology
5 Key Insights On Dexcom’s Stelo & Abbott’s Lingo Glucose Monitors
AI in medtech is taking off. Here are 4 trends to watch in 2025.
Beyond Patching: Securing Medical Devices Postmarket
New AFib treatments show promise
FIRE1 Secures $120 Million Financing to Revolutionize Heart Failure Care

Share This Article